Haematology Cell Counters Market - Size and Forecast [2021-2031]
The Haematology Cell Counters Market is expected to register a CAGR of 6.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Automatic Hematology Analyzers, Semiautomatic Hematology Analyzers). The report further presents analysis based on Application (Clinical Diagnostics, Research Applications). The report is further segmented based on End User (Hospitals, Research and Academic Laboratories, Others). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Haematology Cell Counters Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Haematology Cell Counters Market Segmentation
Type- Automatic Hematology Analyzers
- Semiautomatic Hematology Analyzers
- Clinical Diagnostics
- Research Applications
- Hospitals
- Research and Academic Laboratories
- Others
Strategic Insights
Haematology Cell Counters Market Growth Drivers- Rising Prevalence of Blood Diseases: The high prevalence of blood diseases such as anemia, leukemia, and other hematological diseases is the main driving force for this hematology cell counters market. Healthcare providers heavily rely on current and latest cell counters with increasing numbers of patients who require proper diagnosis that necessitates efficient treatment and management, therefore driving the market.
- Technological Advancements: Advancements in the technology of hematology cell counters form a key driving force in the market. For instance, improvements in automated counting, increased accuracy, as well as ease of user interface lead to enhanced blood analysis efficiency. These products not only make the laboratory work easier but are also contributing to better patient results; hence health institutions are installing more of them.
- Increasing Demand for Point-of-Care Testing: The expanding application base of point-of-care testing (POCT) fuels the demand for cell counters for hematology. Consumer preference for quick diagnosis capabilities in healthcare delivery will see providers turning towards portable and user-friendly cell counters for immediate attention through timely intervention and better patient management in geographies.
- Miniaturization and Portability: Hematology cell counters are miniaturized and portable. Compact, user-friendly devices allow for point-of-care settings or direct testing in remote areas on the spot. This shift increases access to diagnostics, improves speed to decision, and ultimately, patient care.
- Emphasis on Workflow Automation: This is changing the hematology cell counters market because of the greater importance of automation in the workflow of the laboratory. Automated systems cut down human errors and provide better throughput that allows a lab to process samples more efficiently. In this trend of automated systems, laboratories are leaning toward extensive usage of advanced analyzers for hematology that easily accept automation.
- Emphasis on Multi-Parameter Analyzers: With demand for multi-parameter hematology analyzers coming out from the need for comprehensive blood analysis in one test, it represents a great step forward toward workflow automation. Such sophisticated instruments help improve workflows because they give more than one result, such as cell counts and morphology assessment, all at once. This progresses to more efficient laboratory operations and better diagnostics among healthcare providers.
- Health Awareness and Preventive Care Worldwide: Rising health awareness and greater emphasis on preventive care are driving the market for hematology cell counters. Individuals have been adopting various measures to improve their health, and resultant routine blood tests have been on the rise. With respect to this trend, it has become challenging for the healthcare facility to stay up in the game by keeping up with the advance hematology equipment.
- Partnering with Telehealth Services: Major innovation for hematology cell counter makers and telehealth service providers would result from collaboration on remote diagnostics. The use of hematology analyzers would be the way healthcare practitioners could conduct remote consultations while monitoring patient health status by integrating these analyzers with telehealth platforms. This synergy could increase access to diagnostic services, especially in underprivileged rural areas, leading to better care of patients.
- Increased Research and Development Focus: With an increase in the emphasis on developing products in hematology, there is scope for innovation in cell counters. As better biotechnology and automation cut through, more complex devices can be manufactured to yield better accuracy and functionality. The trend makes easy investments in R&D, contributing to differentiation in the market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Haematology Cell Counters Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Haematology Cell Counters Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the haematology cell counters market are:
1. Rising Prevalence of Blood Diseases.
2. Increasing Demand for Point-of-Care Testing.
The haematology cell counters market is expected to grow at a CAGR of 6.5%.
North America region accounts for highest revenue share in haematology cell counters market.
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%).
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023 - 2031).
Sysmex, Danaher Corporation (Beckman Coulter, Inc.), and Siemens Healthcare GmbH are the major companies operating in the haematology cell counters market.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Haematology Cell Counters Market - By Type
1.3.2 Haematology Cell Counters Market - By Application
1.3.3 Haematology Cell Counters Market - By End User
1.3.4 Haematology Cell Counters Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HAEMATOLOGY CELL COUNTERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HAEMATOLOGY CELL COUNTERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HAEMATOLOGY CELL COUNTERS MARKET - GLOBAL MARKET ANALYSIS
6.1. HAEMATOLOGY CELL COUNTERS - GLOBAL MARKET OVERVIEW
6.2. HAEMATOLOGY CELL COUNTERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HAEMATOLOGY CELL COUNTERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. AUTOMATIC HEMATOLOGY ANALYZERS
7.3.1. Overview
7.3.2. Automatic Hematology Analyzers Market Forecast and Analysis
7.4. SEMIAUTOMATIC HEMATOLOGY ANALYZERS
7.4.1. Overview
7.4.2. Semiautomatic Hematology Analyzers Market Forecast and Analysis
8. HAEMATOLOGY CELL COUNTERS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CLINICAL DIAGNOSTICS
8.3.1. Overview
8.3.2. Clinical Diagnostics Market Forecast and Analysis
8.4. RESEARCH APPLICATIONS
8.4.1. Overview
8.4.2. Research Applications Market Forecast and Analysis
9. HAEMATOLOGY CELL COUNTERS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RESEARCH AND ACADEMIC LABORATORIES
9.4.1. Overview
9.4.2. Research and Academic Laboratories Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. HAEMATOLOGY CELL COUNTERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Haematology Cell Counters Market Overview
10.1.2 North America Haematology Cell Counters Market Forecasts and Analysis
10.1.3 North America Haematology Cell Counters Market Forecasts and Analysis - By Type
10.1.4 North America Haematology Cell Counters Market Forecasts and Analysis - By Application
10.1.5 North America Haematology Cell Counters Market Forecasts and Analysis - By End User
10.1.6 North America Haematology Cell Counters Market Forecasts and Analysis - By Countries
10.1.6.1 United States Haematology Cell Counters Market
10.1.6.1.1 United States Haematology Cell Counters Market by Type
10.1.6.1.2 United States Haematology Cell Counters Market by Application
10.1.6.1.3 United States Haematology Cell Counters Market by End User
10.1.6.2 Canada Haematology Cell Counters Market
10.1.6.2.1 Canada Haematology Cell Counters Market by Type
10.1.6.2.2 Canada Haematology Cell Counters Market by Application
10.1.6.2.3 Canada Haematology Cell Counters Market by End User
10.1.6.3 Mexico Haematology Cell Counters Market
10.1.6.3.1 Mexico Haematology Cell Counters Market by Type
10.1.6.3.2 Mexico Haematology Cell Counters Market by Application
10.1.6.3.3 Mexico Haematology Cell Counters Market by End User
10.2. EUROPE
10.2.1 Europe Haematology Cell Counters Market Overview
10.2.2 Europe Haematology Cell Counters Market Forecasts and Analysis
10.2.3 Europe Haematology Cell Counters Market Forecasts and Analysis - By Type
10.2.4 Europe Haematology Cell Counters Market Forecasts and Analysis - By Application
10.2.5 Europe Haematology Cell Counters Market Forecasts and Analysis - By End User
10.2.6 Europe Haematology Cell Counters Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Haematology Cell Counters Market
10.2.6.1.1 Germany Haematology Cell Counters Market by Type
10.2.6.1.2 Germany Haematology Cell Counters Market by Application
10.2.6.1.3 Germany Haematology Cell Counters Market by End User
10.2.6.2 France Haematology Cell Counters Market
10.2.6.2.1 France Haematology Cell Counters Market by Type
10.2.6.2.2 France Haematology Cell Counters Market by Application
10.2.6.2.3 France Haematology Cell Counters Market by End User
10.2.6.3 Italy Haematology Cell Counters Market
10.2.6.3.1 Italy Haematology Cell Counters Market by Type
10.2.6.3.2 Italy Haematology Cell Counters Market by Application
10.2.6.3.3 Italy Haematology Cell Counters Market by End User
10.2.6.4 Spain Haematology Cell Counters Market
10.2.6.4.1 Spain Haematology Cell Counters Market by Type
10.2.6.4.2 Spain Haematology Cell Counters Market by Application
10.2.6.4.3 Spain Haematology Cell Counters Market by End User
10.2.6.5 United Kingdom Haematology Cell Counters Market
10.2.6.5.1 United Kingdom Haematology Cell Counters Market by Type
10.2.6.5.2 United Kingdom Haematology Cell Counters Market by Application
10.2.6.5.3 United Kingdom Haematology Cell Counters Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Haematology Cell Counters Market Overview
10.3.2 Asia-Pacific Haematology Cell Counters Market Forecasts and Analysis
10.3.3 Asia-Pacific Haematology Cell Counters Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Haematology Cell Counters Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Haematology Cell Counters Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Haematology Cell Counters Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Haematology Cell Counters Market
10.3.6.1.1 Australia Haematology Cell Counters Market by Type
10.3.6.1.2 Australia Haematology Cell Counters Market by Application
10.3.6.1.3 Australia Haematology Cell Counters Market by End User
10.3.6.2 China Haematology Cell Counters Market
10.3.6.2.1 China Haematology Cell Counters Market by Type
10.3.6.2.2 China Haematology Cell Counters Market by Application
10.3.6.2.3 China Haematology Cell Counters Market by End User
10.3.6.3 India Haematology Cell Counters Market
10.3.6.3.1 India Haematology Cell Counters Market by Type
10.3.6.3.2 India Haematology Cell Counters Market by Application
10.3.6.3.3 India Haematology Cell Counters Market by End User
10.3.6.4 Japan Haematology Cell Counters Market
10.3.6.4.1 Japan Haematology Cell Counters Market by Type
10.3.6.4.2 Japan Haematology Cell Counters Market by Application
10.3.6.4.3 Japan Haematology Cell Counters Market by End User
10.3.6.5 South Korea Haematology Cell Counters Market
10.3.6.5.1 South Korea Haematology Cell Counters Market by Type
10.3.6.5.2 South Korea Haematology Cell Counters Market by Application
10.3.6.5.3 South Korea Haematology Cell Counters Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Haematology Cell Counters Market Overview
10.4.2 Middle East and Africa Haematology Cell Counters Market Forecasts and Analysis
10.4.3 Middle East and Africa Haematology Cell Counters Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Haematology Cell Counters Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Haematology Cell Counters Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Haematology Cell Counters Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Haematology Cell Counters Market
10.4.6.1.1 South Africa Haematology Cell Counters Market by Type
10.4.6.1.2 South Africa Haematology Cell Counters Market by Application
10.4.6.1.3 South Africa Haematology Cell Counters Market by End User
10.4.6.2 Saudi Arabia Haematology Cell Counters Market
10.4.6.2.1 Saudi Arabia Haematology Cell Counters Market by Type
10.4.6.2.2 Saudi Arabia Haematology Cell Counters Market by Application
10.4.6.2.3 Saudi Arabia Haematology Cell Counters Market by End User
10.4.6.3 U.A.E Haematology Cell Counters Market
10.4.6.3.1 U.A.E Haematology Cell Counters Market by Type
10.4.6.3.2 U.A.E Haematology Cell Counters Market by Application
10.4.6.3.3 U.A.E Haematology Cell Counters Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Haematology Cell Counters Market Overview
10.5.2 South and Central America Haematology Cell Counters Market Forecasts and Analysis
10.5.3 South and Central America Haematology Cell Counters Market Forecasts and Analysis - By Type
10.5.4 South and Central America Haematology Cell Counters Market Forecasts and Analysis - By Application
10.5.5 South and Central America Haematology Cell Counters Market Forecasts and Analysis - By End User
10.5.6 South and Central America Haematology Cell Counters Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Haematology Cell Counters Market
10.5.6.1.1 Brazil Haematology Cell Counters Market by Type
10.5.6.1.2 Brazil Haematology Cell Counters Market by Application
10.5.6.1.3 Brazil Haematology Cell Counters Market by End User
10.5.6.2 Argentina Haematology Cell Counters Market
10.5.6.2.1 Argentina Haematology Cell Counters Market by Type
10.5.6.2.2 Argentina Haematology Cell Counters Market by Application
10.5.6.2.3 Argentina Haematology Cell Counters Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HAEMATOLOGY CELL COUNTERS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HAEMATOLOGY CELL COUNTERS MARKET, KEY COMPANY PROFILES
13.1. SYSMEX
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. DANAHER CORPORATION (BECKMAN COULTER, INC.)
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SIEMENS AG (SIEMENS HEALTHCARE GMBH)
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIO-RAD LABORATORIES, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NIHON KOHDEN CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HORIBA, LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. F. HOFFMANN-LA ROCHE LTD
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. HYCEL MEDICAL
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Sysmex
2. Abbott
3. Danaher Corporation (Beckman Coulter, Inc.)
4. Siemens AG (Siemens Healthcare GmbH)
5. Bio-Rad Laboratories, Inc.
6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
7. Nihon Kohden Corporation
8. HORIBA, Ltd
9. F. Hoffmann-La Roche Ltd
10. Hycel Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For